Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Zydus Pharmaceuticals (USA) Inc recalls Erythromycin Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Products
  • Erythromycin Tablets
Where it was sold

Nationwide within the U.S

Nationwide

Units affected
10,992 bottles
About this recall
Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3).